Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Amylyx Pharmaceuticals, Inc. - Common Stock (NQ: AMLX ) 5.190 -0.040 (-0.76%) Streaming Delayed Price Updated: 4:00 PM EST, Nov 21, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 1,889,364 Open 5.230 Bid (Size) 5.150 (10) Ask (Size) 5.420 (1) Prev. Close 5.230 Today's Range 4.980 - 5.416 52wk Range 1.575 - 19.95 Shares Outstanding N/A Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Crude Oil Rises Sharply; US Homebuilder Sentiment Surges In November November 18, 2024 Via Benzinga Exposures Fossil Fuels Twist Bioscience Posts Upbeat Results, Joins Tesla, Amylyx Pharmaceuticals, Regenxbio And Other Big Stocks Moving Higher On Monday November 18, 2024 Via Benzinga Performance YTD -65.33% -65.33% 1 Month +14.57% +14.57% 3 Month +133.78% +133.78% 6 Month +191.57% +191.57% 1 Year -59.17% -59.17% More News Read More This Robinhood Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday November 18, 2024 Via Benzinga Amylyx Pharmaceuticals Reports Third Quarter 2024 Financial Results November 07, 2024 From Amylyx Pharmaceuticals, Inc. Via Business Wire Analyst Ratings For Amylyx Pharma July 12, 2024 Via Benzinga 6 Analysts Assess Amylyx Pharma: What You Need To Know June 24, 2024 Via Benzinga Breaking Down Amylyx Pharma: 9 Analysts Share Their Views May 10, 2024 Via Benzinga Amylyx Pharmaceuticals to Report Third Quarter 2024 Financial Results on November 7, 2024 November 04, 2024 From Amylyx Pharmaceuticals, Inc. Via Business Wire Why Amylyx Pharmaceuticals Stock Was So Healthy This Week October 18, 2024 Via The Motley Fool Amylyx Pharmaceuticals Announces Positive Topline Results from Phase 2 HELIOS Clinical Trial Demonstrating Sustained Improvements with AMX0035 in People Living with Wolfram Syndrome October 17, 2024 From Amylyx Pharmaceuticals, Inc. Via Business Wire Amylyx Pharmaceuticals to Host Virtual Webcast to Discuss Topline Results from Phase 2 HELIOS Study of AMX0035 in Wolfram Syndrome on October 17, 2024 October 15, 2024 From Amylyx Pharmaceuticals, Inc. Via Business Wire Reneo Pharmaceuticals And 2 Other Stocks Under $5 Executives Are Buying September 17, 2024 Via Benzinga Amylyx Pharmaceuticals to Participate in Upcoming Investor Conferences August 28, 2024 From Amylyx Pharmaceuticals, Inc. Via Business Wire Amylyx Pharmaceuticals Announces Publication of Data Showing the Encouraging Effects of AMX0035 on Cerebrospinal Fluid Biomarkers of Core Alzheimer’s Disease Pathology and Neurodegeneration August 12, 2024 From Amylyx Pharmaceuticals, Inc. Via Business Wire Amylyx Pharmaceuticals Reports Second Quarter 2024 Financial Results August 08, 2024 From Amylyx Pharmaceuticals, Inc. Via Business Wire Amylyx Pharmaceuticals to Report Second Quarter 2024 Financial Results on August 8, 2024 August 05, 2024 From Amylyx Pharmaceuticals, Inc. Via Business Wire Amylyx Pharmaceuticals Receives Orphan Drug Designation From the European Commission for AMX0035 for the Treatment of Wolfram Syndrome August 02, 2024 From Amylyx Pharmaceuticals, Inc. Via Business Wire NVIDIA To Rally More Than 33%? Here Are 10 Top Analyst Forecasts For Friday July 12, 2024 Via Benzinga Why Is Small Cap Amylyx Pharmaceuticals Stock Trading Higher On Wednesday? July 10, 2024 Via Benzinga Amylyx Pharmaceuticals Announces Acquisition of Phase 3-ready GLP-1 Receptor Antagonist (Avexitide) with FDA Breakthrough Therapy Designation July 10, 2024 From Amylyx Pharmaceuticals, Inc. Via Business Wire Amylyx Pharmaceuticals to Host Conference Call to Discuss the Acquisition of Avexitide July 09, 2024 From Amylyx Pharmaceuticals, Inc. Via Business Wire Amylyx Pharmaceuticals to Present at the Goldman Sachs 45th Annual Global Healthcare Conference June 04, 2024 From Amylyx Pharmaceuticals, Inc. Via Business Wire AMLX Stock Earnings: Amylyx Pharma Misses EPS, Misses Revenue for Q1 2024 May 09, 2024 Via InvestorPlace Amylyx Pharmaceuticals Reports First Quarter 2024 Financial Results May 09, 2024 From Amylyx Pharmaceuticals, Inc. Via Business Wire Amylyx Pharmaceuticals to Present at the 2024 Bank of America Health Care Conference May 08, 2024 From Amylyx Pharmaceuticals, Inc. Via Business Wire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
